M. A. S. Moore

535 total citations
12 papers, 436 citations indexed

About

M. A. S. Moore is a scholar working on Immunology, Hematology and Physiology. According to data from OpenAlex, M. A. S. Moore has authored 12 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Hematology and 4 papers in Physiology. Recurrent topics in M. A. S. Moore's work include Immune Response and Inflammation (4 papers), Erythrocyte Function and Pathophysiology (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). M. A. S. Moore is often cited by papers focused on Immune Response and Inflammation (4 papers), Erythrocyte Function and Pathophysiology (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). M. A. S. Moore collaborates with scholars based in United States, Australia and United Kingdom. M. A. S. Moore's co-authors include JI Kurland, PW Kincade, N Williams, R G Crystal, Beat M. Frey, Nicholas C. Dracopoli, Gene K. Potter, C. D. R. Dunn, Susan L. Groshen and E G Wright and has published in prestigious journals such as The Journal of Experimental Medicine, Immunology and Cell Biology and Cell Proliferation.

In The Last Decade

M. A. S. Moore

12 papers receiving 380 citations

Peers

M. A. S. Moore

IMMUN

HEMAT

MB

PHYSI

PHARM

Jeanette Osban United States

M Kawakita Japan

Andrew C. Palfreeman United Kingdom

Cristina Tassi Italy

Kazuhiko Yamamoto Japan

Barbro Näsman‐Glaser Sweden

Jörg Schnyder Switzerland

Ligita Novikovs United States

Tatsuya Sasakawa Japan

Nicoletta Arduino Italy

Jeanette Osban United States

M. A. S. Moore

244 ×1.3

IMMUN

87 ×0.6

HEMAT

202 ×2.0

MB

18 ×0.3

PHYSI

83 ×1.3

PHARM

Citations per year, relative to M. A. S. Moore M. A. S. Moore (= 1×) peers Jeanette Osban

Countries citing papers authored by M. A. S. Moore

Since Specialization

Citations

This map shows the geographic impact of M. A. S. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. S. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. S. Moore more than expected).

Fields of papers citing papers by M. A. S. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. S. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. S. Moore. The network helps show where M. A. S. Moore may publish in the future.

Co-authorship network of co-authors of M. A. S. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. S. Moore. A scholar is included among the top collaborators of M. A. S. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. S. Moore. M. A. S. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Frey, Beat M., et al.. (1998). [Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis].. PubMed. 128(42). 1587–92. 12 indexed citations

2.

Potter, Gene K., et al.. (1985). Action of 1,25-(OH)2D3 in nude mice bearing transplantable human myelogenous leukemic cell lines.. PubMed. 13(8). 722–32. 10 indexed citations

3.

Bakács, Tibor, Ian Kimber, & M. A. S. Moore. (1983). Human K cell-mediated haemolysis: determination of the cytotoxic capacity and antibody sensitization requirements of T lymphocyte enriched and depleted populations.. PubMed. 12(4). 209–15. 2 indexed citations

4.

Dunn, C. D. R., et al.. (1982). Production of presumptive humoral haematopoietic regulators in canine cyclic haematopoiesis. Cell Proliferation. 15(1). 1–10. 8 indexed citations

5.

Kurland, JI, et al.. (1980). Synthesis and release of erythroid colony- and burst-potentiating activities by purified populations of murine peritoneal macrophages. The Journal of Experimental Medicine. 151(4). 839–852. 55 indexed citations

6.

Kurland, JI, et al.. (1979). Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. The Journal of Experimental Medicine. 150(2). 277–292. 180 indexed citations

7.

Williams, N, et al.. (1978). Effect of Myleran On Murine Hemopoiesis. Cell Proliferation. 11(4). 369–375. 3 indexed citations

8.

Moore, M. A. S., et al.. (1978). Abrogation of BCG-contact induced tumour inhibition by silica: implications for the mechanism of action.. PubMed. 38. 233–9. 3 indexed citations

9.

Kurland, JI, PW Kincade, & M. A. S. Moore. (1977). Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors. The Journal of Experimental Medicine. 146(5). 1420–1435. 110 indexed citations

10.

Gabourel, John D., et al.. (1977). Effect of sodium salicylate on human and mouse granulopoiesis in vitro. Arthritis & Rheumatism. 20(1). 59–64. 4 indexed citations

11.

Williams, N, et al.. (1974). DENSITY SEPARATION AND CHARACTERISATION OF HUMAN BLOOD LEUCOCYTES, INCLUDING T AND B LYMPHOCYTES. Immunology and Cell Biology. 52(3). 491–503. 8 indexed citations

12.

Moore, M. A. S. & N Williams. (1973). ANALYSIS OF PROLIFERATION AND DIFFERENTIATION OF FOETAL GRANULOCYTE‐MACROPHAGE PROGENITOR CELLS IN HAEMOPOIETIC TISSUE*. Cell Proliferation. 6(5). 461–476. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact